Search

everythinglearnresearchcommunity

for

Search:↓

Herbal nano-formulations show potential for effective skin delivery but need more research.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Cyclosporine A can reduce inflammation in dogs with sebaceous adenitis, but ongoing treatment is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Early treatment of superficial fungal infections in immunocompromised patients is crucial.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Proper education can prevent traction alopecia in women of color.

Tailor treatments for vitiligo to patient needs for best results.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.